Flourish As You Age

BRAIN - The FDA's Controversial Approval of Aduhelm

Michael C Patterson Season 2 Episode 5

Comments? Send me a text message.

The FDA recently approved the first new drug for Alzheimer's in the last 18 years. .   Why are we not celebrating? Because there  are a slew of concerns about the approval decision. Ten out of eleven members of an independent review board voted against approval. The eleventh couldn't decide.  At least three of these reviewer have resigned in protest. In this podcast I review four of the main concerns about the FDA approval of Aduhelm. 

Support the show

If you want to support this work, click above, subscribe to the MINDRAMP Podcast, or sign up for the free Flourish As You Age newsletter for reviews of current research, reflections, updates, and special extras from my book-in-progress